FDA Announces Recall of Sterile Drug Products from Cantrell Drug Company

Today, the Food and Drug Administration (FDA) announced Cantrell Drug Company is voluntarily recalling certain unexpired sterile drug products due to lack of sterility assurance.

Visit FDA’s website for a full list of drugs included in the recall. The list includes several drug products that are used in ophthalmology. 

Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening. 

The recalled products were distributed nationwide to health care facilities from May 25 to October 31, 2016.

Cantrell Drug Company will begin notifying its customers by email and phone and is arranging for the return of all recalled products. Consumers who have product subject to the recall should stop using it and contact the company.

To return medication or request assistance related to this recall, contact Cantrell Drug Company at 877-666-5222, Monday through Friday between 9 a.m. and 5 p.m. CST.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

If you have additional questions, please contact Jillian Winans, regulatory affairs specialist, at jwinans@ascrs.org or 703-591-2220.